Un Unusual Tumor Association in Acromegaly Abstract #1913

Introduction: Acromegaly is associated with an increased risk for malignancies. Only a case of pseudomyxoma peritonei with ovarian and appendicular sequential tumors in acromegaly was described
Aim(s): We report the case of appendicular adenocarcinoma in acromegaly in progression despite controlled disease
Materials and methods: A 59 years old woman underwent partial neurosurgery in 2006 for invasive GHoma. Pt started treatment with somatostatin analogues and she underwent second neurosurgery in 2008. In 2010 for resistant disease pt was enrolled in PAOLA study with normalization of GH secretion. In January 2015 a left ovarian cyst was found and pt was followed-up with gynecological ultrasound. In September 2016 for increase in size and appearance of a contralateral lesion pt was oophorectomized-hysterectomized. Histological examination showed infiltration of mucinous adenocarcinoma of probably gastrointestinal origin with a neuroendocrine cell line differentiation. Colonoscopy and gastroscopy were negative. Ecoendoscopy-guided biopsy of gastric wall revealed metastasis of mucinous adenocarcinoma
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Clinical cases/reports
Presenting Author: Chiara Bima

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1907 Pancreatic Neuroendocrine Tumors in MEN1 Disease: A Monocentrice Longitudinal and Prognostic Study
Introduction: In MEN1+ patients (MEN+), pNETs are considered to be high risk for multiple, malignant and aggressive tumors.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Pathology, grading, staging
Presenting Author: md Sabrina Chiloiro
Keywords: pNETs, MEN, prognosis
#2227 Screening Benefits in MEN1-Associated Pituitary Adenomas
Introduction: MEN1 is an autosomal-dominant syndrome characterized by tumors of the parathyroid glands (95%), endocrine pancreatic-gastroenteric tract (40%), and pituitary gland (30%).
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: md Sabrina Chiloiro
#3048 Somatostatin Analogs or Active Surveillance in Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors
Introduction: Non-functioning (NF), sporadic pancreatic neuroendocrine tumors (pNETs) have usually an indolent behavior, but sometimes show an unpredictable aggressiveness. Surgery is the first-choice for localized tumors >2 cm. Unresectable or metastatic lesions expressing somatostatin receptors (SSTRs) are treated with Somatostatin analogs (SSAs). No evidence of SSAs efficacy exists in tumors ≤2 cm, for which active surveillance has been proposed.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - Chemotherapy Somatostatin analogues, Interferon
Presenting Author: PhD Giovanni Schinzari
#1522 Non-secreting Pancreatic Neuroendocrine Tumors Co-esistenting with ACTH-dependent Cushing Disease
Introduction: Pancreatic neuroendocrine tumors (pNET) occur occasionally as cause of ectopic ACTH-dependent Cushing disease (ECD).
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Clinical cases/reports
Presenting Author: Sabrina Chiloiro
Keywords: NET
#2186 Management of Aggressive Medullary Thyroid Cancer
Introduction: Medullary thyroid cancer (MTC) is a neuroendocrine tumor of the C cells of thyroid gland characterized by significant morbidity.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Case reports
Presenting Author: Chiara Bima